IdentificationGeneric Name(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamideDrugBank Accession NumberDB06837BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide (DB06837)× CloseWeightAverage: 370.3991 Monoisotopic: 370.152871824 Chemical FormulaC20H22N2O5SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUA disintegrin and metalloproteinase with thrombospondin motifs 5Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as indanes. These are compounds containing an indane moiety, which consists of a cyclopentane fused to a benzene ring.KingdomOrganic compoundsSuper ClassBenzenoidsClassIndanesSub ClassNot AvailableDirect ParentIndanesAlternative Parents1-hydroxy-4-unsubstituted benzenoids / 1-hydroxy-2-unsubstituted benzenoids / N-acyl amines / Benzene and substituted derivatives / Secondary carboxylic acid amides / Secondary alcohols / Hydroxamic acids / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 2 moreSubstituents1-hydroxy-2-unsubstituted benzenoid / 1-hydroxy-4-unsubstituted benzenoid / Alcohol / Aromatic homopolycyclic compound / Carbonyl group / Carboxamide group / Carboxylic acid derivative / Fatty acyl / Fatty amide / Hydrocarbon derivative / Hydroxamic acid / Indane / Monocyclic benzene moiety / N-acyl-amine / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Phenol / Secondary alcohol / Secondary carboxylic acid amide


 show 13 moreMolecular FrameworkAromatic homopolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyVXDKQRWTOJFQKH-BJZITVGISA-NInChIInChI=1S/C20H22N2O5/c23-15-6-3-4-12(9-15)8-14(11-18(25)22-27)20(26)21-19-16-7-2-1-5-13(16)10-17(19)24/h1-7,9,14,17,19,23-24,27H,8,10-11H2,(H,21,26)(H,22,25)/t14-,17-,19+/m1/s1IUPAC Name(2R)-N'-hydroxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-2-[(3-hydroxyphenyl)methyl]butanediamideSMILES[H][C@](CC(=O)NO)(CC1=CC(O)=CC=C1)C(=O)N[C@@]1([H])C2=C(C[C@@]1([H])O)C=CC=C2ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound11143173PubChem Substance99443308ChemSpider9318285BindingDB50104965ChEMBLCHEMBL8943ZINCZINC000013436282PDBe Ligand099PDB Entries3hygClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.162 mg/mLALOGPSlogP0.7ALOGPSlogP1.22ChemaxonlogS-3.4ALOGPSpKa (Strongest Acidic)8.79ChemaxonpKa (Strongest Basic)-1.4ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count5ChemaxonHydrogen Donor Count5ChemaxonPolar Surface Area118.89 Å2ChemaxonRotatable Bond Count6ChemaxonRefractivity98.65 m3·mol-1ChemaxonPolarizability38.08 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+0.9536Blood Brain Barrier+0.715Caco-2 permeable-0.7405P-glycoprotein substrateNon-substrate0.5678P-glycoprotein inhibitor INon-inhibitor0.913P-glycoprotein inhibitor IINon-inhibitor0.9797Renal organic cation transporterNon-inhibitor0.9441CYP450 2C9 substrateNon-substrate0.7678CYP450 2D6 substrateNon-substrate0.8302CYP450 3A4 substrateSubstrate0.5502CYP450 1A2 substrateNon-inhibitor0.6807CYP450 2C9 inhibitorNon-inhibitor0.8171CYP450 2D6 inhibitorNon-inhibitor0.8849CYP450 2C19 inhibitorNon-inhibitor0.7033CYP450 3A4 inhibitorNon-inhibitor0.8353CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7328Ames testAMES toxic0.6418CarcinogenicityNon-carcinogens0.8439BiodegradationNot ready biodegradable0.9082Rat acute toxicity2.4098 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9838hERG inhibition (predictor II)Non-inhibitor0.7662  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. A disintegrin and metalloproteinase with thrombospondin motifs 5KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionCleaves aggrecan, a cartilage proteoglycan, and may be involved in its turnover. May play an important role in the destruction of aggrecan in arthritic diseases. May play a role in proteolytic proc...Gene NameADAMTS5Uniprot IDQ9UNA0Uniprot NameA disintegrin and metalloproteinase with thrombospondin motifs 5Molecular Weight101716.955 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:17 / Updated at June 12, 2020 16:52 